1041P ODI-2001, a personalized combinatorial immunotherapy shows antitumoral activity across different syngeneic mice tumor models, including 4T1

Autor: Marschall, P., Matta, C., Hugel, C., Matta, J., Limacher, J-M.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S697-S698
Databáze: ScienceDirect